Mental-Health-Ward Deprescribing Interviews Identified an Interface Problem

Medication continuation can reflect service processes as well as patient symptoms.

What the paper found

Twenty-nine healthcare professionals from eleven NHS organizations were interviewed about benzodiazepine and Z-drug deprescribing on adult mental-health wards. Themes included local culture, patient factors, practical measures and the primary–secondary care interface.

Limits of the evidence

These are professional accounts rather than observed treatment-effect estimates. Interview sampling and interpretation limit generalization, and reported barriers do not establish which intervention would improve cessation or safety.

Implications for case review

When reviewing continuity of prescribing, examine responsibility at admission, discharge and follow-up. The study cannot establish that a particular continuation resulted from a systems failure or that stopping would have been preferable. It identifies questions for record review, not proof of an individual error.

Source and related reading

Source: PMC12639134, supplied full-text paper. Findings are paraphrased; forensic implications are an interpretation.

Related: Cirrhosis Deprescribing Interviews Identify Barriers, Not Proof That Stopping Benzodiazepines Prevents Encephalopathy.